Secondary acute myeloid leukemia following treatment with VP16- containing regimens for non-Hodgkin's lymphoma

E. Orlandi, M. Lazzarino, P. Bernasconi, C. Astori, C. Bernasconi

Research output: Contribution to journalArticle

Abstract

We report on two patients who developed a secondary acute myeloid leukemia (sAL) after treatment for non-Hodgkin's lymphoma (NHL) with regimens containing low to intermediate doses of VP16. Clinical and hematologic features in these two patients were consistent with epipodophyllotoxin- associated sAL. In one case, a rearrangement of chromosome band 11q23 was detected.

Original languageEnglish
Pages (from-to)758-759
Number of pages2
JournalHaematologica
Volume83
Issue number8
Publication statusPublished - 1998

Keywords

  • Secondary leukemia
  • VP16

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Secondary acute myeloid leukemia following treatment with VP16- containing regimens for non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

  • Cite this